Back to search results

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Abroad (travel likely)Recruiting

Conditions

Glioblastoma · Glioblastoma Multiforme · Glioblastoma, IDH-wildtype · Glioblastoma Multiforme of Brain · Glioblastoma Multiforme, Adult · Recurrent Glioblastoma · Astrocytoma, Malignant · Astrocytoma of Brain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Mitchel Berger, MD PhD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Brian Nahed, MD PhD)

  • University Hospital Leuven, Leuven, Belgium

    Contact: Study coordinator (Steven De Vleeschouwer, MD PhD)

  • University Hospital Heidelberg, Heidelberg, Germany

    Contact: Study coordinator (Christine Jungk, Dr. med.)

  • Technical University Munich, Munich, Germany

    Contact: Study coordinator (Arthur Wagner, MD)

  • Erasmus MC, Rotterdam, South Holland, Netherlands

    Contact: Study coordinator (Arnaud Vincent, MD PhD) · a.vincent@erasmusmc.nl · +31639428949
    Contact: Study coordinator (Jasper Gerritsen, MD) · j.gerritsen@erasmusmc.nl · +31629119553

  • Medical Center Haaglanden, The Hague, South Holland, Netherlands

    Contact: Study coordinator (Marike Broekman, MD PhD) · m.broekman@haaglandenmc.nl · +31639758253

  • Inselspital Universitätsspital Bern, Bern, Switzerland

    Contact: Study coordinator (Philippe Schucht, MD PhD)
Study leads

  • Jasper Gerritsen, MD PhD

    Principal Investigator

    Erasmus Medical Center

View source on ClinicalTrials.gov(opens in a new tab)